2/15/2024

Clarity Raises $16M in Seed Funding led by Walden Catalyst and Bessemer Venture Partners

1/24/2024

Voltron Data Acquires Claypot AI As It Unlocks the Power of the Largest Datasets for AI

1/23/2024

Ingonyama is a next-generation semiconductor company focusing on Zero-Knowledge Proof (ZKP or ZK) hardware acceleration. The company’s mission is to lower the barrier of entry to ZKPs by making them inexpensive, accessible and fast.

1/3/2024

ArteraAI Receives Medicare Payment Rate for the ArteraAI Prostate Cancer Test: This is the first-of-its-kind AI-enabled test to provide predictive and prognostic results

12/1/2023

Nature Biotechnology’s annual survey highlights academic start ups that are correcting misfolded or disordered proteins, creating second-generation GPCR agonists, building a new gene delivery platform and mining cancer genomes for novel targets.

11/27/2023

Many enterprise teams have already deployed LLMs in production. However, for enterprise AI teams, the biggest hurdle to deploying production-ready Generative AI products remains the fear of model hallucinations. Discover Galileo's LLM Hallucination Index

11/22/2023

AI21 Labs' vision for reliable enterprise AI has been boosted by further funding from Intel Capital and Comcast Ventures.

10/17/2023

Artera's multi-modal AI test has been successfully validated for advanced prostate cancer. In collaboration with the UCL Cancer Institute, Artera validated its model on various trials, and have shown that it can effectively prognosticate patient outcomes.

10/2/2023

Combining experimental and computational tools, Peptone is targeting disordered regions of proteins previously thought to be undruggable.

9/4/2023

Generative AI tools are on the rise. For LLMs to provide value, they must be able to operate on all data. Today’s policies dictate what data can and cannot be shared. While such regulations are critical to protect our privacy, it creates enormous friction.

9/1/2023

We’re thrilled to announce the completion of a successful Series C funding round of $155 million at a valuation of $1.4 billion, marking a major milestone AI21 Labs journey to bring reliable AI to the enterprise.

8/15/2023

Ingonyama presents their ZK movie for a general audience. The company is not just navigating today’s challenges but preparing for a future in which Zero-Knowledge is a cornerstone of our online interactions.

7/1/2023

New AHA president Joseph Wu (Greenstone Bio) is a pioneering scientist with an adventurous backstory.

5/16/2023

Revolutionizing Industrial Inspection with its Four-Legged Robotic Workforce.

5/16/2023

ANYbotics Secures $50M Series B Funding to Revolutionize Industrial Inspection with its Four-Legged Robotic Workforce

4/19/2023

Walden Catalyst Ventures leads investment round to support high-volume operations

4/13/2023

AI21 Labs partners with Amazon to offer top-performing, easily accessible foundation models

4/12/2023

With the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the disease

4/6/2023

Enhancing the Writing Experience for Hundreds of Millions of People Around the World

4/5/2023

Who will be the next health tech success story?

3/23/2023

Artera Launches with $90 Million in Funding to Personalize Cancer Therapy With Multimodal AI

1/18/2023

Wordtune Spices: AI21 Labs intros an AI writing assistant that cites its sources

11/1/2022

Our New Investment in Galileo

6/28/2022

Our New Investment in Opaque Systems

7/11/2022

Our New Investment in Peptone

7/11/2022

Our New Investment in Voltron Data

5/3/2022

Portfolio News: Our Investment in MindsDB.

2/23/2022

Portfolio News: Our investment in Voltron Data